Tenille Dashwood has become a US Citizen. The Australian born pro wrestler is a former TNA and WWE roster member, having ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam ...

77% of genital psoriasis patients saw clear/almost clear skin vs. 21% on placebo after 16 weeks. PN-881 showed 70x greater potency than secukinumab in vitro and effective reduction in skin ...

Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary ...

Roflumilast foam 0.3% applied once daily led to significantly greater clearance of scalp and body plaque psoriasis lesions and more rapid itch reduction than placebo over eight weeks.

Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic agents due to an ability to regulate inflammatory signaling pathways.

This happened at the intersection of Dashwood Drive and Hillcroft Street. Police said the driver, a man, was driving south on Hillcroft when he hit the pedestrian. Witnesses told HPD the driver ...

66% of patients with scalp psoriasis achieved a scalp-specific Investigator's Global Assessment (ss-IGA) c score of 0/1 compared to 11% receiving placebo (P<0.001) at 16 weeks.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 8, patients treated with roflumilast saw ...

You may face a higher risk of developing a Candida fungus infection if you have psoriasis. This can make your psoriasis symptoms worse. It can also lead to other health issues, such as thrush or ...